# CJC-1295 Ipamorelin (cjc-1295-ipamorelin.com)

> CJC-1295 and ipamorelin, study by study. The publisher of this site also runs the OXpeptides shop (disclosed). The published trials with verified DOIs, and the checks a buyer can make on a listing of the CJC-1295 / ipamorelin blend in Europe. Informational content, not medical advice. CJC-1295 and ipamorelin are investigational compounds, not approved by the FDA or the EMA; research use only, not for human or veterinary use. This site gives no doses or protocols.

## Main page
- [CJC-1295 ipamorelin: what the human trials show (2026)](https://cjc-1295-ipamorelin.com/): quick answer, the GH pulsatility figure, the human data, where to get the blend in Europe.

## Guides
- [Sermorelin vs CJC-1295 ipamorelin](https://cjc-1295-ipamorelin.com/sermorelin-vs-cjc-1295-ipamorelin/): three molecules compared on structure, receptor, half-life, data and status.
- [CJC-1295 peptide](https://cjc-1295-ipamorelin.com/cjc-1295-peptide/): what CJC-1295 is, DAC vs no DAC, the 5.8 to 8.1-day half-life, the two human trials and the phase 2 that stopped.
- [CJC-1295 side effects](https://cjc-1295-ipamorelin.com/cjc-1295-side-effects/): the human record, class effects, the IGF-1 and glucose questions.
- [CJC-1295 DAC vs no DAC](https://cjc-1295-ipamorelin.com/cjc-1295-dac-vs-no-dac/): half-life, pulse versus plateau, which form a blend uses.
- [Tesamorelin ipamorelin vs CJC-1295 ipamorelin](https://cjc-1295-ipamorelin.com/cjc-1295-ipamorelin-vs-tesamorelin/): the two blends compared on data and regulatory status.
- [CJC-1295 ipamorelin on Reddit](https://cjc-1295-ipamorelin.com/cjc-1295-ipamorelin-reddit/): the seven recurring questions, answered from peer-reviewed papers.
- [Hormone de croissance : prix en France (FR)](https://cjc-1295-ipamorelin.com/fr/hormone-de-croissance-prix/): public French price of every somatropin presentation (BDPM, 29 Sep 2026), 20.28 to 25.32 EUR per mg, and the GH secretagogues studied in research.

## About
- [About and method](https://cjc-1295-ipamorelin.com/about/)
- [Editorial policy](https://cjc-1295-ipamorelin.com/editorial-policy/)
- Contact: contact@cjc-1295-ipamorelin.com

## Key facts
- CJC-1295 with DAC: 30-residue GHRH(1-29) analogue with four substitutions and an albumin-binding maleimide linker; human half-life 5.8 to 8.1 days (Teichman et al. 2006, doi:10.1210/jc.2005-1536).
- In a trial, one week after a single administration, trough GH was 7.5-fold higher, mean GH 46 % higher, IGF-1 45 % higher, pulses unchanged (Ionescu and Frohman 2006, doi:10.1210/jc.2006-1702).
- Ipamorelin: pentapeptide Aib-His-D-2-Nal-D-Phe-Lys-NH2, ghrelin-receptor agonist, no ACTH or cortisol release in swine at more than 200 times the ED50 (Raun et al. 1998, doi:10.1530/eje.0.1390552); terminal half-life 2 hours in men (Gobburu et al. 1999, doi:10.1023/A:1018955126402).
- No published human trial has administered CJC-1295 and ipamorelin together.
- The research-market blend holds the linker-free CJC-1295 (Mod GRF 1-29, 3,367.9 g/mol) and ipamorelin (711.9 g/mol) in equal mass. The supplier page this site links to: https://oxpeptides.com/products/cjc-1295-ipamorelin (research use only).